Cancer drug target is promising lead for new TB treatments

Nov 17, 2010

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis (TB), according to a study published in Microbiology on 17 November.

The human equivalent of this has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies. Scientists at the University of Birmingham have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.

The enzyme called IMPDH is crucial for the survival of both human and . It is involved in the first stage of producing guanine –the raw materials needed for DNA synthesis - as well as many other housekeeping processes that keep the cell alive and functioning.

The researchers identified the three genes in M. tuberculosis that encode IMPDH and then screened a library of 16 compounds that were likely to impede its function to some extent. Of the 16 diphenyl urea (DPU) compounds, 3 were able to inhibit IMPDH by more than 90%, killing M. cells.

Project leader Professor Gurdyal Besra explained why IMPDH is a promising target to tackle TB. "IMPDH is essential for cells to proliferate rapidly, which is one of the characteristics of microbial infection as well as human cancers. IMPDH has been used as a target in some anti-cancer drugs, as blocking the enzyme can prevent proliferation of the cell and induce cell death. Our findings show that inhibiting the bacterial version of IMPDH is a strategy that could be exploited for anti-TB drugs," he said. "The DPU compounds we tested have selective activity against Mycobacterium species, meaning that any future drugs based on these would be specific and would not affect human cells."

9 million people are newly diagnosed with TB each year with increasing incidences of multi-drug resistant (MDR)-TB and extensively drug resistant (XDR)-TB. "In the face of growing resistance to current therapies, we desperately need new treatments for TB that are safe and effective," stressed Professor Besra. "We are tapping the potential of a so far unexploited target which could lead to the synthesis of a novel anti-tubercular drug and our findings, so far are extremely encouraging," he said.

Explore further: Some anti-inflammatory drugs affect more than their targets

Provided by Society for General Microbiology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Drug-resistant tuberculosis rife in China

Dec 11, 2008

Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average. Nationwide research published in the open access journal BMC Infectious Diseases has shown that almost 10% of Chinese TB cases are re ...

New avenues for overcoming tuberculosis drug resistance

Apr 27, 2010

Tuberculosis (TB) continues to be a global health problem, in part due to the exceptional drug resistance displayed by the TB-causing agent, Mycobacterium tuberculosis. Beyond even acquired drug resistance, these bacteria are al ...

WHO warns of drug-resistant TB

Sep 06, 2006

The World Health Organization in Switzerland has warned of a new strain of tuberculosis that is rapidly spreading and cannot be treated with current drugs.

HIV/AIDS linked to drug resistant TB

Nov 16, 2006

U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.

Recommended for you

Some anti-inflammatory drugs affect more than their targets

16 hours ago

Researchers have discovered that three commonly used nonsteroidal anti-inflammatory drugs, or NSAIDs, alter the activity of enzymes within cell membranes. Their finding suggests that, if taken at higher-than-approved ...

Researchers discover new strategy germs use to invade cells

Aug 20, 2014

The hospital germ Pseudomonas aeruginosa wraps itself into the membrane of human cells: A team led by Dr. Thorsten Eierhoff and Junior Professor Dr. Winfried Römer from the Institute of Biology II, members of the Cluster ...

Progress in the fight against harmful fungi

Aug 20, 2014

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida ...

How steroid hormones enable plants to grow

Aug 19, 2014

Plants can adapt extremely quickly to changes in their environment. Hormones, chemical messengers that are activated in direct response to light and temperature stimuli help them achieve this. Plant steroid ...

User comments : 0